Forest plot demonstrating significantly decreased relative (a) and absolute (b) risk of death at the study endpoint in patients administered MSCs (experimental) compared to patients not administered MSCs (control). Control groups received standard of care for COVID-19 at the time of hospital admission, which varied depending on the institution.